DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Merrem PWS IV- Generic sale global - API Insight, 2020
US$ 500.00
This report can be delivered to the clients within 48 Hours 'Merrem PWS IV- Generic sale global - API Insight, 2020' report by DelveInsight provides product and API manufacturers details across US,...
January 2020
30 pages
Portal Hypertension - Pipeline Insight, 2020
US$ 1,250.00
This report can be delivered to the clients within 48-72 Hours Portal Hypertension Overview 'Portal Hypertension Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Pres...
January 2020
60 pages
T-Bact - API Insight, 2020
US$ 500.00
This report can be delivered to the clients within 48 Hours 'T-Bact - API Insight, 2020' report by DelveInsight provides product and API manufacturers details across US, Europe, China and India for...
January 2020
30 pages
Ichthyosis- Pipeline Insight, 2019
US$ 1,250.00
This report can be delivered to the clients within 48 Hours 'Ichthyosis- Pipeline Insight, 2019' report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across...
October 2019
60 pages
Vascular Ehlers-Danlos Syndrome - Pipeline Insight, 2019
US$ 1,250.00
This report can be delivered to the clients within 48 Hours 'Vascular Ehlers-Danlos Syndrome - Pipeline Insight, 2019' report by DelveInsight outlays comprehensive insights of present scenario and g...
October 2019
60 pages
Uveitis - Epidemiology Forecast-2028
US$ 3,250.00
... be delivered to the clients within 24 hours DelveInsight’s ‘Uveitis - Epidemiology Forecast-2028’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Uveitis in the United States, EU5 (Germany, Spain ...
September 2019
100 pages
Cystinuria- Market Insights, Epidemiology, and Market Forecast-2028
US$ 6,250.00
... 2017–2028 Cystinuria - Disease Understanding and Treatment Algorithm Cystinuria is an autosomal ... Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Cystinuria Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market ...
September 2019
145 pages
Hepatic Encephalopathy- Market Insights, Epidemiology, and Market Forecast-2028
US$ 6,250.00
... . Hepatic Encephalopathy Report Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Hepatic Encephalopathy Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs ...
September 2019
160 pages
Carcinoid Syndrome- Pipeline Insight, 2019
US$ 1,250.00
... Carcinoid Syndrome- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Carcinoid Syndrome pipeline ... 's proprietary databases, company/university websites, clinical trial registries, conferences, ...
August 2019
60 pages
Chagas Disease - Pipeline Insight, 2019
US$ 1,250.00
... Chagas Disease pipeline landscape is provided which includes the disease overview and Chagas Disease treatment guidelines. The assessment part of the report embraces, in depth Chagas Disease commercial assessment and clinical ...
August 2019
60 pages
Chronic Neuropathic Pain (CNP) - Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Chronic Neuropathic Pain treatment guidelines. The assessment part of the report embraces, in depth Chronic Neuropathic Pain commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Gorlin Syndrome - Pipeline Insight, 2019
US$ 1,250.00
... Gorlin Syndrome treatment guidelines. The assessment part of the report embraces, in depth Gorlin Syndrome commercial assessment and clinical assessment of the pipeline ... traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor ...
August 2019
60 pages
Graves’ Ophthalmopathy - Pipeline Insight, 2019
US$ 1,250.00
... Graves’ Ophthalmopathy Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC ...
August 2019
60 pages
Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2019
US$ 1,250.00
... therapy (which has been the standard treatment for HSDD for a long time), Testosterone treatment (Menopausal women with HSDD). Hypoactive Sexual Desire Disorder (HSDD) Pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...
August 2019
60 pages
Hypothalamic Obesity (HO) - Pipeline Insight, 2019
US$ 1,250.00
... Hypothalamic Obesity treatment guidelines. The assessment part of the report embraces, in depth Hypothalamic Obesity commercial assessment and clinical assessment of the pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...
August 2019
60 pages
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Idiopathic CD4+ Lymphocytopenia treatment guidelines. The assessment part of the report embraces, in depth Idiopathic CD4+ Lymphocytopenia commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Lactose Intolerance - Pipeline Insight, 2019
US$ 1,250.00
... Lactose malassimilation. Lactose Intolerance Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... proprietary databases, company/university websites, clinical trial registries, conferences, ...
August 2019
60 pages
Lambert-Eaton Myasthenic Syndrome (LEMS)- Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Lambert-Eaton Myasthenic Syndrome (LEMS) treatment guidelines. The assessment part of the report embraces, in depth Lambert-Eaton Myasthenic Syndrome (LEMS) commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Phosphoglucomutase (PGM 1) Deficiency- Pipeline Insight, 2019
US$ 1,250.00
... report which includes Company-Company Collaborations (Licensing / Partnering), Company-Academia Collaborations, and Acquisition analysis in both Graphical and tabulated form. Phosphoglucomutase (PGM 1) Deficiency Clinical Assessment of products ...
August 2019
60 pages
Post-Transplant Lymphoproliferative Disorder- Pipeline Insight, 2019
US$ 1,250.00
... post-transplant lymphoproliferative disease. Early diagnosis and prompt treatment of these disorders are extremely important. Post-Transplant Lymphoproliferative Disorder Pipeline Development Activities The report provides insights ... databases, company/university websites, clinical trial registries, conferences ...
August 2019
60 pages
Primary Biliary Cholangitis - Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Primary Biliary Cholangitis treatment guidelines. The assessment part of the report embraces, in depth Primary Biliary Cholangitis commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Primary Progressive Aphasia - Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Primary Progressive Aphasia treatment guidelines. The assessment part of the report embraces, in depth Primary Progressive Aphasia commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Proteus Syndrome - Pipeline Insight, 2019
US$ 1,250.00
... Proteus syndrome. Proteus Syndrome Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... 's proprietary databases, company/university websites, clinical trial registries, conferences, SEC ...
August 2019
60 pages
Pruritis - Pipeline Insight, 2019
US$ 1,250.00
... 24 Hours "Pruritis - Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present ... Drugs under development as a monotherapy or combination therapy are also included. It also analyses key players involved in Pruritis ... databases, company/university websites, clinical trial registries, ...
August 2019
60 pages
Pseudoxanthoma Elasticum- Pipeline Insight, 2019
US$ 1,250.00
... Pseudoxanthoma Elasticum- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Pseudoxanthoma Elasticum pipeline ... databases, company/university websites, clinical trial registries, conferences ...
August 2019
60 pages
